MATR3 (Matrin-3) is a nuclear matrix protein that forms distinct nuclear bodies (MATR3-NBs) functioning as RNA processing hubs for spliceosome recycling and transcription termination. This hypothesis proposes that ALS-linked MATR3 mutations (p.S85C, p.F115C, p.G497E) disrupt MATR3-NB integrity, causing aberrant spliceosome dynamics, intron retention accumulation, and nuclear RNA export defects that trigger motor neuron death. The mechanistic prediction is that MATR3-NBs serve as transient storage and assembly platforms for U snRNP components; their disruption by disease mutations disperses spliceosome machinery, causing widespread splicing dysregulation including cryptic splice site activation.
...No AI visual card yet
Curated pathway diagram from expert analysis
flowchart TD
A["MATR3 ALS Mutation
Nuclear Matrix Protein"]
B["MATR3 Nuclear Body Disruption
RNA Processing Hub Loss"]
C["U1 snRNP and Spliceosome Recycling Defect
SNRPB SNRNP70 Misrouting"]
D["Intron Retention and Splicing Errors
Nascent RNA Quality Loss"]
E["Nuclear RNA Export Stress
Aberrant Transcript Accumulation"]
F["Motor Neuron RNA Toxicity
Proteostasis Burden"]
G["ALS Motor Neuron Death
Nuclear Body Failure Axis"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
style B fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.
No price history recorded yet
No clinical trials data available
Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.
No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.
Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.
High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.
Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.
Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.
No DepMap CRISPR Chronos data found for MATR3,U1 snRNP,SNRPB,SNRNP70, splicing machinery,spliceosome.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No governance decisions recorded for this hypothesis.
Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.
No knowledge graph edges recorded
No comments yet. Be the first to comment!